VMISA

Serial Number 85243910
606

Registration Progress

Application Filed
Feb 16, 2011
Under Examination
Aug 2, 2011
Approved for Publication
Jun 7, 2011
Published for Opposition
Jun 7, 2011
Registered

Trademark Image

VMISA

Basic Information

Serial Number
85243910
Filing Date
February 16, 2011
Published for Opposition
June 7, 2011
Abandonment Date
March 5, 2012
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 5, 2012
Classes
005

Rights Holder

Noven Therapeutics, LLC

16
Address
11960 S.W. 144th Street
Miami, FL 33186

Ownership History

Noven Therapeutics, LLC

Original Applicant
16
Miami, FL

Noven Therapeutics, LLC

Owner at Publication
16
Miami, FL

Legal Representation

Attorney
Jay G. Kolman, Esq.

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

11 events
Date Code Type Description
Mar 5, 2012 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Mar 5, 2012 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Aug 2, 2011 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 7, 2011 PUBO A PUBLISHED FOR OPPOSITION
Jun 7, 2011 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 4, 2011 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
May 3, 2011 ALIE A ASSIGNED TO LIE
Apr 18, 2011 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 14, 2011 DOCK D ASSIGNED TO EXAMINER
Feb 22, 2011 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 19, 2011 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for use in the treatment of gynecological disorders and conditions, namely, gynecological disorders conditions affecting nervousness, depression, mood, anxiety, and cognitive function, perspiration, headache, palpitation, sleep, and bone and joint pain; pharmaceutical preparations for use in the treatment of sexual dysfunction; pharmaceutical preparations and substances for the treatment of hormonal related diseases, disorders, and deficiencies; pharmaceutical preparations for use in the treatment of neurological diseases and disorders, psychiatric diseases and disorders, psychological diseases and disorders, cognitive impairment disorders, sleep disorders, panic disorders and anxiety disorders; pharmaceutical preparations and substances for use in the treatment, alleviation and prevention of thermoregulatory dysfunctions and vasomotor symptoms including hot flashes, hot flushes, night awakenings, night sweats, and other such disorders and conditions associated with perimenopause, menopause and hormonal deficiencies
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005